1	Influence	_	NN	_	_	0	ROOT	_	_
2	of	_	IN	_	_	1	NMOD	_	_
3	tetramerisation	_	NN	_	_	2	PMOD	_	_
4	on	_	IN	_	_	1	NMOD	_	_
5	site-specific	_	JJ	_	_	7	NMOD	_	_
6	post-translational	_	JJ	_	_	7	NMOD	_	_
7	modifications	_	NNS	_	_	4	PMOD	_	_
8	of	_	IN	_	_	7	NMOD	_	_
9	p53	_	NN	_	_	8	PMOD	_	_
10	:	_	:	_	_	1	P	_	_
11	comparison	_	NN	_	_	1	APPO	_	_
12	of	_	IN	_	_	11	NMOD	_	_
13	human	_	JJ	_	_	19	NMOD	_	_
14	and	_	CC	_	_	13	COORD	_	_
15	murine	_	JJ	_	_	14	CONJ	_	_
16	p53	_	NN	_	_	19	NMOD	_	_
17	tumor	_	NN	_	_	19	NMOD	_	_
18	suppressor	_	NN	_	_	19	NMOD	_	_
19	protein	_	NN	_	_	12	PMOD	_	_
20	.	_	.	_	_	1	P	_	_
		
1	The	_	DT	_	_	5	NMOD	_	_
2	tumor	_	NN	_	_	5	NMOD	_	_
3	suppressor	_	NN	_	_	5	NMOD	_	_
4	protein	_	NN	_	_	5	NMOD	_	_
5	p53	_	NN	_	_	6	VMOD	_	_
6	is	_	VBZ	_	_	0	ROOT	_	_
7	considered	_	VBN	_	_	6	VC	_	_
8	the	_	DT	_	_	10	NMOD	_	_
9	"	_	``	_	_	10	P	_	_
10	Guardian	_	NN	_	_	7	VMOD	_	_
11	of	_	IN	_	_	10	NMOD	_	_
12	the	_	DT	_	_	13	NMOD	_	_
13	Genome	_	NN	_	_	11	PMOD	_	_
14	"	_	POS	_	_	13	SUFFIX	_	_
15	,	_	,	_	_	10	P	_	_
16	crucial	_	JJ	_	_	10	APPO	_	_
17	for	_	IN	_	_	16	AMOD	_	_
18	cell	_	NN	_	_	20	NMOD	_	_
19	cycle	_	NN	_	_	20	NMOD	_	_
20	control	_	NN	_	_	17	PMOD	_	_
21	and	_	CC	_	_	7	COORD	_	_
22	mutated	_	VBN	_	_	21	CONJ	_	_
23	in	_	IN	_	_	22	VMOD	_	_
24	over	_	IN	_	_	25	DEP	_	_
25	50	_	CD	_	_	26	NMOD	_	_
26	%	_	NN	_	_	23	PMOD	_	_
27	of	_	IN	_	_	26	NMOD	_	_
28	human	_	JJ	_	_	29	NMOD	_	_
29	cancers	_	NNS	_	_	27	PMOD	_	_
30	.	_	.	_	_	6	P	_	_
		
1	Following	_	VBG	_	_	12	VMOD	_	_
2	cellular	_	JJ	_	_	3	NMOD	_	_
3	stress	_	NN	_	_	1	PMOD	_	_
4	,	_	,	_	_	12	P	_	_
5	post-translational	_	JJ	_	_	6	NMOD	_	_
6	modifications	_	NNS	_	_	12	VMOD	_	_
7	such	_	JJ	_	_	8	DEP	_	_
8	as	_	IN	_	_	6	NMOD	_	_
9	phosphorylation	_	NN	_	_	8	PMOD	_	_
10	and	_	CC	_	_	9	COORD	_	_
11	acetylation	_	NN	_	_	10	CONJ	_	_
12	stabilise	_	VB	_	_	0	ROOT	_	_
13	and	_	CC	_	_	12	COORD	_	_
14	activate	_	VB	_	_	13	CONJ	_	_
15	p53	_	NN	_	_	14	VMOD	_	_
16	for	_	IN	_	_	14	VMOD	_	_
17	cell	_	NN	_	_	19	NMOD	_	_
18	cycle	_	NN	_	_	19	NMOD	_	_
19	arrest	_	NN	_	_	16	PMOD	_	_
20	,	_	,	_	_	19	P	_	_
21	DNA	_	NN	_	_	22	NMOD	_	_
22	repair	_	NN	_	_	19	COORD	_	_
23	,	_	,	_	_	22	P	_	_
24	apoptosis	_	NN	_	_	22	COORD	_	_
25	or	_	CC	_	_	24	COORD	_	_
26	senescence	_	NN	_	_	25	CONJ	_	_
27	.	_	.	_	_	12	P	_	_
		
1	p53	_	NN	_	_	2	NMOD	_	_
2	protein	_	NN	_	_	3	VMOD	_	_
3	functions	_	VBZ	_	_	0	ROOT	_	_
4	as	_	IN	_	_	3	VMOD	_	_
5	a	_	DT	_	_	6	NMOD	_	_
6	tetramer	_	NN	_	_	4	PMOD	_	_
7	and	_	CC	_	_	3	COORD	_	_
8	we	_	PRP	_	_	9	VMOD	_	_
9	have	_	VBP	_	_	7	CONJ	_	_
10	shown	_	VBN	_	_	9	VC	_	_
11	that	_	IN	_	_	10	VMOD	_	_
12	loss	_	NN	_	_	20	VMOD	_	_
13	of	_	IN	_	_	12	NMOD	_	_
14	tetramerisation	_	NN	_	_	13	PMOD	_	_
15	and	_	CC	_	_	12	COORD	_	_
16	changes	_	NNS	_	_	15	CONJ	_	_
17	at	_	IN	_	_	16	NMOD	_	_
18	the	_	DT	_	_	19	NMOD	_	_
19	N-terminus	_	NN	_	_	17	PMOD	_	_
20	influence	_	VBP	_	_	11	SUB	_	_
21	the	_	DT	_	_	22	NMOD	_	_
22	recovery	_	NN	_	_	20	VMOD	_	_
23	of	_	IN	_	_	22	NMOD	_	_
24	wild	_	JJ	_	_	26	NMOD	_	_
25	type	_	NN	_	_	26	NMOD	_	_
26	p53	_	NN	_	_	23	PMOD	_	_
27	'	_	``	_	_	28	P	_	_
28	status	_	NN	_	_	26	PRN	_	_
29	'	_	''	_	_	28	P	_	_
30	.	_	.	_	_	3	P	_	_
		
1	To	_	TO	_	_	11	VMOD	_	_
2	investigate	_	VB	_	_	1	IM	_	_
3	the	_	DT	_	_	4	NMOD	_	_
4	relationship	_	NN	_	_	2	VMOD	_	_
5	between	_	IN	_	_	4	NMOD	_	_
6	tetramerisation	_	NN	_	_	5	PMOD	_	_
7	and	_	CC	_	_	6	COORD	_	_
8	post-translational	_	JJ	_	_	9	NMOD	_	_
9	modifications	_	NNS	_	_	7	CONJ	_	_
10	we	_	PRP	_	_	11	VMOD	_	_
11	examined	_	VBD	_	_	0	ROOT	_	_
12	a	_	DT	_	_	13	NMOD	_	_
13	range	_	NN	_	_	11	VMOD	_	_
14	of	_	IN	_	_	13	NMOD	_	_
15	site-specific	_	JJ	_	_	16	NMOD	_	_
16	modifications	_	NNS	_	_	14	PMOD	_	_
17	in	_	IN	_	_	16	NMOD	_	_
18	wild	_	JJ	_	_	27	NMOD	_	_
19	type	_	NN	_	_	27	COORD	_	_
20	and	_	CC	_	_	27	COORD	_	_
21	dimeric	_	JJ	_	_	27	COORD	_	_
22	mutant	_	JJ	_	_	27	COORD	_	_
23	(	_	(	_	_	27	P	_	_
24	M340Q/L344R	_	NN	_	_	27	COORD	_	_
25	)	_	)	_	_	27	P	_	_
26	murine	_	JJ	_	_	27	COORD	_	_
27	p53	_	NN	_	_	17	PMOD	_	_
28	expressed	_	VBN	_	_	27	APPO	_	_
29	in	_	IN	_	_	28	VMOD	_	_
30	MEFs	_	NN	_	_	29	PMOD	_	_
31	p53(-/-)	_	CD	_	_	30	NMOD	_	_
32	and	_	CC	_	_	17	COORD	_	_
33	in	_	IN	_	_	32	CONJ	_	_
34	wild	_	JJ	_	_	35	NMOD	_	_
35	type	_	NN	_	_	33	PMOD	_	_
36	,	_	,	_	_	35	P	_	_
37	monomeric	_	JJ	_	_	47	NMOD	_	_
38	(	_	(	_	_	39	P	_	_
39	L344P	_	NN	_	_	37	PRN	_	_
40	)	_	)	_	_	39	P	_	_
41	and	_	CC	_	_	37	COORD	_	_
42	dimeric	_	JJ	_	_	41	CONJ	_	_
43	(	_	(	_	_	44	P	_	_
44	M340Q/L344R	_	NN	_	_	47	PRN	_	_
45	)	_	)	_	_	44	P	_	_
46	human	_	JJ	_	_	47	NMOD	_	_
47	p53	_	NN	_	_	35	APPO	_	_
48	expressed	_	VBN	_	_	47	APPO	_	_
49	in	_	IN	_	_	48	VMOD	_	_
50	HCT116	_	NN	_	_	52	NMOD	_	_
51	p53(-/-)	_	NN	_	_	52	NMOD	_	_
52	cells	_	NNS	_	_	49	PMOD	_	_
53	.	_	.	_	_	11	P	_	_
		
1	Using	_	VBG	_	_	5	VMOD	_	_
2	site-specific	_	JJ	_	_	3	NMOD	_	_
3	antibodies	_	NNS	_	_	1	VMOD	_	_
4	we	_	PRP	_	_	5	VMOD	_	_
5	demonstrate	_	VBP	_	_	0	ROOT	_	_
6	that	_	IN	_	_	5	VMOD	_	_
7	in	_	IN	_	_	12	VMOD	_	_
8	murine	_	JJ	_	_	9	NMOD	_	_
9	p53	_	NN	_	_	7	PMOD	_	_
10	,	_	,	_	_	12	P	_	_
11	S15	_	NN	_	_	12	VMOD	_	_
12	is	_	VBZ	_	_	6	SUB	_	_
13	phosphorylated	_	VBN	_	_	12	VC	_	_
14	in	_	IN	_	_	13	VMOD	_	_
15	a	_	DT	_	_	17	NMOD	_	_
16	tetramerisation-dependent	_	JJ	_	_	17	NMOD	_	_
17	manner	_	NN	_	_	14	PMOD	_	_
18	.	_	.	_	_	5	P	_	_
		
1	In	_	IN	_	_	8	VMOD	_	_
2	contrast	_	NN	_	_	1	PMOD	_	_
3	,	_	,	_	_	8	P	_	_
4	human	_	JJ	_	_	7	NMOD	_	_
5	p53	_	NN	_	_	7	NMOD	_	_
6	S15	_	NN	_	_	7	NMOD	_	_
7	phosphorylation	_	NN	_	_	8	VMOD	_	_
8	is	_	VBZ	_	_	0	ROOT	_	_
9	not	_	RB	_	_	8	VMOD	_	_
10	tetramerisation-dependent	_	JJ	_	_	8	VMOD	_	_
11	.	_	.	_	_	8	P	_	_
		
1	Inability	_	NN	_	_	9	VMOD	_	_
2	to	_	TO	_	_	1	APPO	_	_
3	form	_	VB	_	_	2	IM	_	_
4	tetramers	_	NNS	_	_	3	VMOD	_	_
5	in	_	IN	_	_	3	VMOD	_	_
6	human	_	JJ	_	_	8	NMOD	_	_
7	p53	_	NN	_	_	8	NMOD	_	_
8	proteins	_	NNS	_	_	5	PMOD	_	_
9	reduced	_	VBD	_	_	0	ROOT	_	_
10	site-specific	_	JJ	_	_	12	NMOD	_	_
11	N-terminal	_	JJ	_	_	12	NMOD	_	_
12	phosphorylation	_	NN	_	_	9	VMOD	_	_
13	at	_	IN	_	_	12	NMOD	_	_
14	S6	_	NN	_	_	13	PMOD	_	_
15	,	_	,	_	_	14	P	_	_
16	S9	_	NN	_	_	14	COORD	_	_
17	and	_	CC	_	_	16	COORD	_	_
18	S46	_	NN	_	_	17	CONJ	_	_
19	and	_	CC	_	_	12	COORD	_	_
20	reduced	_	VBN	_	_	22	NMOD	_	_
21	C-terminal	_	JJ	_	_	22	NMOD	_	_
22	phosphorylation	_	NN	_	_	19	CONJ	_	_
23	and	_	CC	_	_	22	COORD	_	_
24	acetylation	_	NN	_	_	23	CONJ	_	_
25	at	_	IN	_	_	22	NMOD	_	_
26	S315	_	NNP	_	_	25	PMOD	_	_
27	and	_	CC	_	_	26	COORD	_	_
28	K382	_	NNP	_	_	27	CONJ	_	_
29	respectively	_	RB	_	_	9	VMOD	_	_
30	.	_	.	_	_	9	P	_	_
		
1	In	_	IN	_	_	6	VMOD	_	_
2	addition	_	NN	_	_	1	PMOD	_	_
3	,	_	,	_	_	6	P	_	_
4	p53	_	NN	_	_	5	NMOD	_	_
5	tetramerisation	_	NN	_	_	6	VMOD	_	_
6	is	_	VBZ	_	_	0	ROOT	_	_
7	required	_	VBN	_	_	6	VC	_	_
8	for	_	IN	_	_	7	VMOD	_	_
9	efficient	_	JJ	_	_	10	NMOD	_	_
10	p21	_	NN	_	_	13	NMOD	_	_
11	and	_	CC	_	_	10	COORD	_	_
12	hdm2	_	NN	_	_	11	CONJ	_	_
13	transcription	_	NN	_	_	8	PMOD	_	_
14	and	_	CC	_	_	13	COORD	_	_
15	protein	_	NN	_	_	16	NMOD	_	_
16	expression	_	NN	_	_	14	CONJ	_	_
17	and	_	CC	_	_	16	COORD	_	_
18	recruitment	_	NN	_	_	17	CONJ	_	_
19	of	_	IN	_	_	18	NMOD	_	_
20	p53	_	NN	_	_	19	PMOD	_	_
21	to	_	TO	_	_	18	NMOD	_	_
22	specific	_	JJ	_	_	24	NMOD	_	_
23	promoter	_	NN	_	_	24	NMOD	_	_
24	regions	_	NNS	_	_	21	PMOD	_	_
25	of	_	IN	_	_	24	NMOD	_	_
26	p21	_	NN	_	_	25	PMOD	_	_
27	and	_	CC	_	_	26	COORD	_	_
28	hdm2	_	NN	_	_	27	CONJ	_	_
29	.	_	.	_	_	6	P	_	_
		
